Abstract 090: The Optimal Time Between Preoperative Embolization and Surgery for Spinal Metastatic Tumors: An Updated Systematic Review & Meta‐Analysis

摘要 090:脊柱转移瘤术前栓塞与手术之间的最佳时间间隔:最新系统评价和荟萃分析

阅读:1

Abstract

INTRODUCTION: This systematic review and meta‐analysis evaluates the impact of surgical timing after preoperative embolization on outcomes in spinal metastases by comparing early (<1 day) and late (>1 day) surgeries. METHODS: In January 2025, a systematic search of PubMed, Embase, and Cochrane yielded a total of 1,764 studies. Among these, seven retrospective studies, involving 357 patients, met the predefined inclusion criteria. Studies comparing early (<1 day) and late (>1 day) surgery after embolization were included. Exclusion criteria comprised non‐original studies, lack of separate timing groups, and indirect blood loss, such as changes in hemoglobin levels. The risk of bias was assessed using the ROBINS‐I tool, and data were analyzed with a random‐effects model implemented in R software. RESULTS: No significant differences were identified in intraoperative blood loss (IBL) (mean difference [MD] = ‐189.56 mL; 95% confidence interval [CI] ‐497.58 to 118.45; p = 0.23), estimated blood loss (EBL) (MD = 16.30 mL; 95% CI ‐85.90 to 118.49; p = 0.75), transfusion requirements (MD = ‐126.95 mL; 95% CI ‐359.08 to 105.18; p = 0.28), or operative time (MD = ‐14.34 minutes; 95% CI ‐30.03 to 1.34; p = 0.07). Furthermore, a subgroup analysis comparing degrees of embolization showed that early surgical intervention significantly reduced IBL in cases of complete embolization (MD = ‐596.23 mL; 95% CI ‐1028.62 to ‐163.84; p < 0.01). CONCLUSIONS: Early surgery following complete embolization of spinal metastases significantly reduces intraoperative blood loss. No statistically significant difference was observed between groups in other outcomes. [Image: see text] [Image: see text]

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。